Commonwealth Equity Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Sell |
14,289
-7,624
| -35% | -$616K | ﹤0.01% | 2508 |
|
|
2025
Q4 | $1.8M | Sell |
21,913
-3,089
| -12% | -$239K | ﹤0.01% | 2077 |
|
|
2025
Q3 | $1.75M | Sell |
25,002
-2,325
| -9% | -$157K | ﹤0.01% | 2114 |
|
|
2025
Q2 | $1.75M | Sell |
27,327
-4,914
| -15% | -$304K | ﹤0.01% | 2098 |
|
|
2025
Q1 | $2.04M | Buy |
32,241
+6,239
| +24% | +$420K | ﹤0.01% | 1897 |
|
|
2024
Q4 | $1.73M | Buy |
26,002
+3,764
| +17% | +$259K | ﹤0.01% | 1975 |
|
|
2024
Q3 | $1.55M | Buy |
22,238
+8,433
| +61% | +$584K | ﹤0.01% | 2005 |
|
|
2024
Q2 | $895K | Sell |
13,805
-57
| -0.4% | -$3.61K | ﹤0.01% | 2371 |
|
|
2024
Q1 | $897K | Buy |
13,862
+256
| +2% | +$16.7K | ﹤0.01% | 2335 |
|
|
2023
Q4 | $896K | Buy |
13,606
+1,418
| +12% | +$82.4K | ﹤0.01% | 2251 |
|
|
2023
Q3 | $695K | Sell |
12,188
-33
| -0.3% | -$2.01K | ﹤0.01% | 2317 |
|
|
2023
Q2 | $749K | Buy |
12,221
+507
| +4% | +$31.6K | ﹤0.01% | 2313 |
|
|
2023
Q1 | $735 | Sell |
11,714
-636
| -5% | -$41K | ﹤0.01% | 2257 |
|
|
2022
Q4 | $784K | Buy |
12,350
+733
| +6% | +$46.5K | ﹤0.01% | 2122 |
|
|
2022
Q3 | $684K | Buy |
11,617
+1,955
| +20% | +$120K | ﹤0.01% | 2177 |
|
|
2022
Q2 | $557K | Sell |
9,662
-173
| -2% | -$9.96K | ﹤0.01% | 2327 |
|
|
2022
Q1 | $610K | Buy |
9,835
+738
| +8% | +$45K | ﹤0.01% | 2359 |
|
|
2021
Q4 | $647K | Sell |
9,097
-421
| -4% | -$30.5K | ﹤0.01% | 2312 |
|
|
2021
Q3 | $712K | Sell |
9,518
-413
| -4% | -$31.5K | ﹤0.01% | 2199 |
|
|
2021
Q2 | $768K | Sell |
9,931
-431
| -4% | -$32K | ﹤0.01% | 2124 |
|
|
2021
Q1 | $764K | Sell |
10,362
-749
| -7% | -$56.6K | ﹤0.01% | 2007 |
|
|
2020
Q4 | $779K | Sell |
11,111
-186
| -2% | -$11.8K | ﹤0.01% | 1821 |
|
|
2020
Q3 | $639K | Buy |
11,297
+2,445
| +28% | +$144K | ﹤0.01% | 1795 |
|
|
2020
Q2 | $515K | Sell |
8,852
-1,566
| -15% | -$85.3K | ﹤0.01% | 1859 |
|
|
2020
Q1 | $484K | Buy |
10,418
+101
| +1% | +$5.27K | ﹤0.01% | 1717 |
|
|
2019
Q4 | $576K | Sell |
10,317
-6,912
| -40% | -$360K | ﹤0.01% | 1800 |
|
|
2019
Q3 | $816K | Sell |
17,229
-505
| -3% | -$25.9K | ﹤0.01% | 1488 |
|
|
2019
Q2 | $949K | Sell |
17,734
-270
| -1% | -$14K | ﹤0.01% | 1374 |
|
|
2019
Q1 | $993K | Buy |
18,004
+551
| +3% | +$29.1K | ﹤0.01% | 1299 |
|
|
2018
Q4 | $821K | Buy |
17,453
+171
| +1% | +$8.79K | ﹤0.01% | 1330 |
|
|
2018
Q3 | $1.03M | Buy |
17,282
+167
| +1% | +$9.74K | ﹤0.01% | 1283 |
|
|
2018
Q2 | $936K | Sell |
17,115
-340
| -2% | -$17.3K | ﹤0.01% | 1314 |
|
|
2018
Q1 | $859K | Sell |
17,455
-437
| -2% | -$22.3K | ﹤0.01% | 1341 |
|
|
2017
Q4 | $844K | Buy |
17,892
+231
| +1% | +$10.8K | ﹤0.01% | 1335 |
|
|
2017
Q3 | $882K | Buy |
17,661
+14
| +0.1% | +$664 | 0.01% | 1255 |
|
|
2017
Q2 | $806K | Sell |
17,647
-4,095
| -19% | -$177K | 0.01% | 1263 |
|
|
2017
Q1 | $919K | Sell |
21,742
-2,147
| -9% | -$90K | 0.01% | 1160 |
|
|
2016
Q4 | $927K | Sell |
23,889
-5,315
| -18% | -$215K | 0.01% | 1075 |
|
|
2016
Q3 | $1.23M | Sell |
29,204
-1,725
| -6% | -$70.8K | 0.01% | 903 |
|
|
2016
Q2 | $1.14M | Sell |
30,929
-2,335
| -7% | -$91.6K | 0.01% | 910 |
|
|
2016
Q1 | $1.27M | Sell |
33,264
-11,402
| -26% | -$443K | 0.01% | 844 |
|
|
2015
Q4 | $2.26M | Buy |
44,666
+1,096
| +3% | +$54.2K | 0.02% | 583 |
|
|
2015
Q3 | $1.99M | Buy |
43,570
+1,545
| +4% | +$86.3K | 0.02% | 598 |
|
|
2015
Q2 | $2.45M | Sell |
42,025
-1,177
| -3% | -$67.3K | 0.02% | 552 |
|
|
2015
Q1 | $2.38M | Buy |
43,202
+1,252
| +3% | +$67.7K | 0.02% | 547 |
|
|
2014
Q4 | $2.11M | Buy |
41,950
+6,567
| +19% | +$321K | 0.02% | 560 |
|
|
2014
Q3 | $1.64M | Buy |
35,383
+1,356
| +4% | +$61.1K | 0.02% | 629 |
|
|
2014
Q2 | $1.49M | Buy |
34,027
+5,163
| +18% | +$209K | 0.02% | 673 |
|
|
2014
Q1 | $1.2M | Buy |
28,864
+1,289
| +5% | +$55.2K | 0.02% | 713 |
|
|
2013
Q4 | $1.02M | Buy |
27,575
+5,048
| +22% | +$181K | 0.01% | 757 |
|
|
2013
Q3 | $790K | Sell |
22,527
-3,540
| -14% | -$117K | 0.01% | 846 |
|
|
2013
Q2 | $753K | Buy |
+26,067
| New | +$741K | 0.01% | 814 |
|
Other funds holding PBE
UCFA
GKWIM
YIA
Commonwealth Equity Services's PBE Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 35% in Q1 2026, selling an estimated $616K and leaving 14,289 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2508.
Commonwealth Equity Services first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.45M in Q2 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.
- Commonwealth Equity Services held 14,289 shares of Invesco Biotechnology & Genome ETF worth $1.13M as of Q1 2026.
- Commonwealth Equity Services sold 7,624 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $616K.
- Invesco Biotechnology & Genome ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2508 holding.
- Commonwealth Equity Services first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Invesco Biotechnology & Genome ETF position peaked at $2.45M in Q2 2015.
- 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.